{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:39:45Z","timestamp":1785220785663,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.clindermatol.2016.10.009","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T08:30:45Z","timestamp":1477557045000},"page":"168-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Hormonal therapies for acne"],"prefix":"10.1016","volume":"35","author":[{"given":"Brittany","family":"Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Thiboutot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clindermatol.2016.10.009_bb0005","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjd.13462","article-title":"A global perspective on the epidemiology of acne","volume":"172","author":"Tan","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0010","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archderm.141.3.333","article-title":"Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women","volume":"141","author":"Cappel","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0015","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamadermatol.2015.4499","article-title":"Insulin resistance and metabolic syndrome in young men with acne","volume":"152","author":"Nagpal","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0020","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jamadermatol.2015.4498","article-title":"Cutaneous findings and systemic associations in women with polycystic ovary syndrome","volume":"152","author":"Schmidt","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0025","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.clindermatol.2004.03.010","article-title":"Acne: hormonal concepts and therapy","volume":"22","author":"Thiboutot","year":"2004","journal-title":"Clin Derm"},{"issue":"suppl 3","key":"10.1016\/j.clindermatol.2016.10.009_bb0030","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1046\/j.0926-9959.2001.00014.x","article-title":"Endocrinological evaluation and hormonal therapy for women with difficult acne","volume":"15","author":"Thiboutot","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0035","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","article-title":"Oral spironolactone improves acne vulgaris and reduces sebum excretion","volume":"111","author":"Goodfellow","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0040","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1468-3083.2005.01072.x","article-title":"Effects and side-effects of spironolactone therapy in women with acne","volume":"19","author":"Yemisci","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0045","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1530\/acta.0.0950540","article-title":"Disturbances in sexual differentiation of rat foetuses following spironolactone treatment","volume":"95","author":"Hecker","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0050","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","article-title":"Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne","volume":"151","author":"Plovanich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0055","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.canep.2013.10.004","article-title":"Spironolactone use and the risk of breast and gynecologic cancers","volume":"37","author":"Biggar","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0060","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1055\/s-0029-1211357","article-title":"Experience in the long-term treatment of patients with hirsutism and\/or acne with cyproterone acetate-containing preparations: efficacy, metabolic, and endocrine effects","volume":"103","author":"van Wayjen","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0065","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/pds.857","article-title":"The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD","volume":"12","author":"Seaman","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0070","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE\/CMA (Belara) and EE\/LNG (Microgynon)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0075","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.2165\/1153874-S0-000000000-00000","article-title":"Ethinylestradiol\/Chlormadinone acetate: dermatological benefits","volume":"12","author":"Guerra-Tapia","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0080","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0190-9622(90)70241-9","article-title":"Treatment of hirsutism with the pure antiandrogen flutamide","volume":"23","author":"Cusan","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0085","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clindermatol.2009.03.006","article-title":"Hormonal therapy for acne: why not as first line therapy? Facts and controversies","volume":"28","author":"Katsambas","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0090","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/BF03348907","article-title":"Treatment with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism","volume":"16","author":"Faloia","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0095","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003987.pub5","article-title":"Combination contraceptives: effects on weight","volume":"29","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0105","series-title":"Endotext [Internet]","article-title":"Contraception. 2014 Nov 11","author":"Sonalkar","year":"2000"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0110","first-page":"1","article-title":"Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review","volume":"1","author":"Horton","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.clindermatol.2016.10.009_bb0115","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions","volume":"107","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2006","journal-title":"Obstet Gynecol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X1630270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X1630270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T02:43:08Z","timestamp":1568515388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X1630270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0738081X1630270X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.10.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal therapies for acne","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}